Metabolically Unhealthy Phenotype: A Key Factor in Determining "Pediatric" Frailty
Related Experiment Video
Updated: Oct 27, 2025

Frailty Assessment in an Aging Mouse Model
Published on: September 23, 2025
Valeria Calcaterra1,2, Hellas Cena3,4, Annamaria Ruggieri5
1Pediatric and Adolescent Unit, Department of Internal Medicine, University of Pavia, 27100 Pavia, Italy.
Insights
Metabolic syndrome (MS) is linked to frailty (FI) in children with disabilities and obesity, similar to elderly individuals. Addressing MS is crucial for pediatric frailty care.
Area of Science:
- Pediatrics
- Geriatrics
- Metabolic Health
Background:
- Frailty (FI) and metabolic syndrome (MS) are linked to poor health outcomes in adults.
- Understanding the connection between FI and MS in pediatric populations is essential.
Purpose of the Study:
- To investigate the prevalence of a metabolically unhealthy phenotype (MUP) in malnourished disabled children, children with obesity, and normal-weight children.
- To compare MUP prevalence in these pediatric groups with elderly individuals at risk of FI.
- To identify potential similarities underlying the risk of FI in specific pediatric groups.
Main Methods:
- Studied 50 malnourished disabled children, 50 children with obesity, 50 normal-weight children, and 21 elderly patients (>75 years).
- Defined MUP by the presence of hypertension, hyperglycemia/diabetes, hypercholesterolemia, or hypertriglyceridemia.
- Utilized body mass index (BMI) standard deviation scores (SDS) for pediatric weight classification.
Main Results:
- Disabled children and children with obesity showed a significantly higher prevalence and risk of MUP compared to normal-weight children.
- MUP prevalence in disabled children was comparable to elderly patients at risk of FI.
- MUP was less prevalent in children with obesity and normal-weight children compared to the elderly group.
Conclusions:
- Metabolic syndrome (MS) may significantly contribute to pediatric frailty (FI).
- Malnutrition and the extremes of aging appear to be key factors in developing frailty.
- A multidisciplinary approach is recommended for managing pediatric frailty.
Abstract:
Frailty (FI) and metabolic syndrome (MS) are each associated with adverse health outcomes. A relationship between FI and MS has previously been described in adults. We considered the prevalence of a metabolically unhealthy phenotype (MUP) in malnourished children with neurological impairment and in subjects with obesity in comparison to a group of elderly individuals at risk of FI, and we did so in order to define the potential similarities that may underline the risk of FI in specific children. We considered 50 undernourished (defined as having a body mass index of BMI ≤ 2, standard deviation score, SDS, according to World Health Organization) disabled children; 50 children with obesity (BMI ≥ 2 SDS); 50 children who were a normal weight (-1 SDS ≤ BMI ≤ +1 SDS); 21 patients who were >75 years old. MUP was defined as the presence of at least one of the following risk factors: hypertension, hyperglycemia or diabetes, hypercholesterolemia, and hypertriglyceridemia. In children with a disability and obesity, a higher prevalence (p < 0.001) and risk (disability OR 54.88, obesity OR 13.37) of MUP was noted compared to children of a normal weight. Compared to elderly patients, the prevalence of MUP did not differ in disabled children. On the contrary, MUP was lower in children with obesity (p < 0.001) and in pediatric subjects of a normal weight (p < 0.01). MS might play a key role in "pediatric" frailty. The extremities of the aging process and malnutrition are likely key factors in the development of FI. A multidisciplinary approach to FI may represent an important milestone for pediatric care.
More Related Videos
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
04:00Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Obesity
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Inborn Errors of Metabolism
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...